Open in interactive viewer → charts, metric popovers & call review

Barco's audio-visual bet: VerVent, the memory squeeze, and a healthcare reset

H1-2026 shows a company that paid for growth (EUR 134M VerVent, net debt EUR 33M, FCF -EUR 37M), front-ran a memory-supply shock, and restructured healthcare around lost surgical contracts — all while reconfirming 11-12% EBITDA.
BAR.BR · Earnings Call · 2026-07-15

All-in on entertainment: the VerVent trade

The defining change at Barco this quarter is strategic, not operational. Management reconfirmed it is going "all in on entertainment," and the VerVent Audio acquisition is the proof — the company now pairs its projection and visualization franchise with Focal and Naim's audio brands, formally integrated as a third BU, "consumer experience," under the entertainment division. For the first two months of ownership it "showed solid growth." CEO An Steegen framed the logic candidly:

We truly believe that a true entertainment experience is a combination of visualization and audio... because by adding audio, of course, we can tap into a bigger addressable market in the entertainment sector.

An Steegen, CEO · 2026-07-15

The VerVent move is genuinely new to Barco's keyword history — audio solutions and the acquisition language barely registered across the prior 12 quarters of earnings commentary ("VerVent Audio" surfaced only as a name, never as a strategy). Near-term it's about bundling home-cinema projectors with Focal/Naim gear; professional audio for cinema and immersive experience is a two-year roadmap — "maybe in the market in the third year." That is a slower payoff than the lifetime-value math Barco applies to its HDR projectors, where management earlier argued “we basically can quote numbers between 8x and 10x for Barco over the lifetime of that projector” — An Steegen, CEO · 2026-02-16. Nor is the price tag cheap — one analyst pegged it at roughly 21x EBITDA on an annualized H1 basis — but management defends it on the ~1.2x revenue multiple and the "one plus one is three" synergy thesis. The optics are still notable: EUR 134M cash out swung the group from net cash to net debt of EUR 33M at mid-year.

Buying memory at the bottom

The other genuinely new theme is the memory and component supply squeeze. CFO Ann Desender attributed the EUR 57M inventory build partly to "advanced purchase of components and memory chips where there are price increases and to be ahead of those to also secure our gross profit margins." The CEO was more direct about the strategy:

We have already bought quite a supply so we can last for at least a couple of months... Wherever we can, we basically include that in our price.

An Steegen, CEO · 2026-07-15

Memory is a fresh word for Barco — it did not register in the prior year of calls — and it puts the company on a crowded global theme: the market's 90-day tape is led by high-bandwidth memory and PCIe Gen 6, and Ericsson's current call separately flagged "component cost inflation impact." Barco's exposure is asymmetric: management says cinema, control rooms, and diagnostic imaging so far show little demand impact, but ClickShare Hub, built on newer memory generations, is where they will "watch out" for price elasticity. The working-capital hit is immediate — free cash flow came in at -EUR 37M for the half, with inventory the big swing — and the CFO named inventory reduction the "big focus area for the second semester."

A healthcare reset framed around lost contracts

Barco's EBITDA weakness (EUR 26M, 6% of sales; net result -EUR 4.8M) traces mostly to healthcare, where surgical continues to bleed after losing large design-in contracts. This is a recurring thread — in February the CEO noted “it takes time to replace contracts that were finished. It's a very long design in time that you see in Surgical” — An Steegen, CEO · 2026-02-16 — but the structural response is new: the entire healthcare division has been put under one leader, John Zhao (formerly of Modality China), to "avoid fragmentation" and "improve execution discipline," e.g. “we have moved now the entire healthcare division under one leadership” — An Steegen, CEO · 2026-07-15. Meanwhile an EUR 8.4M restructuring, including closing the Norway R&D facility, is meant to deliver more impact in the back half.

The big contracts theme is the drag, but there is a counterpoint in the portfolio: control rooms were the highlight (control platform now 43% of sales and growing fast), and diagnostic imaging is riding its replacement wave off a trusted install base. On the premium side, HDR by Barco now targets 100+ systems installed by year-end with 45+ blockbusters secured — up from 35 a year ago — a commercial-readiness story aligned with the market's wider launch and product-readiness momentum. Recurring revenues reached 13% of sales, adding a structural margin cushion. Management reconfirmed full-year sales growth (including VerVent) and an 11-12% EBITDA margin, and defended the 2028 targets (EUR 1.1B sales, 15% margin) despite the portfolio reshuffle. “After a difficult first quarter, we saw the momentum improving in the second quarter” — An Steegen, CEO · 2026-07-15 — but with FCF negative, net debt, and a two-year audio roadmap ahead, the market's bet is on execution, not promise.